Global Finance News
08 May 2026, 09:15
Microchip Technology Jumps 3.4% as Recovery Accelerates Far Ahead of Expectations
Chandler, May 7, 2026 — Shares in Microchip Technology gained 3.4% in premarket after the embedded control chipmaker reported a fourth fiscal quarter that dramatically beat its own guidance, with revenue and earnings both landing well above the top end of prior forecasts and forward guidance pointing to continued strong acceleration.
Net sales of $1.311 billion grew 35.1% year-over-year and 10.6% sequentially — both the year-over-year and sequential figures are striking for a company that was navigating a severe inventory correction just a few quarters ago. The midpoint of prior guidance had been $1.260 billion, meaning Microchip beat its own revenue forecast by over $50 million. Non-GAAP EPS of $0.57 similarly crushed the $0.48 to $0.52 guidance range, and non-GAAP operating margin expanded to 30.6%, a significant step toward the company's longer-term targets.
CEO Steve Sanghi was direct in framing the results as evidence that the company's nine-point recovery plan is working. Distributor inventory declined to 26 days, near the low end of historical ranges, and internal inventory fell by $22 million in the quarter, bringing total inventory reduction to $320.9 million from the December 2024 peak. Normalizing channel inventory is the precondition for higher factory utilization and the margin expansion that follows, and the data suggests that milestone is close.
The forward guidance carried equal weight with investors. Q1 fiscal 2027 revenue is guided to $1.442 to $1.469 billion at the midpoint — up 35.3% year-over-year and 11% sequentially — with non-GAAP EPS of $0.67 to $0.71, a substantial step up from the $0.57 just delivered. Non-GAAP operating margin is expected to reach 33% to 34.5%, reflecting the operating leverage that comes as factories ramp utilization to meet recovering demand.
Data center and AI-related design wins in high-speed connectivity and compute added a growth narrative beyond the cyclical recovery, giving investors confidence that Microchip's rebound has durable secular support beneath it.
Chandler, May 7, 2026 — Shares in Microchip Technology gained 3.4% in premarket after the embedded control chipmaker reported a fourth fiscal quarter that dramatically beat its own guidance, with revenue and earnings both landing well above the top end of prior forecasts and forward guidance pointing to continued strong acceleration.
Net sales of $1.311 billion grew 35.1% year-over-year and 10.6% sequentially — both the year-over-year and sequential figures are striking for a company that was navigating a severe inventory correction just a few quarters ago. The midpoint of prior guidance had been $1.260 billion, meaning Microchip beat its own revenue forecast by over $50 million. Non-GAAP EPS of $0.57 similarly crushed the $0.48 to $0.52 guidance range, and non-GAAP operating margin expanded to 30.6%, a significant step toward the company's longer-term targets.
CEO Steve Sanghi was direct in framing the results as evidence that the company's nine-point recovery plan is working. Distributor inventory declined to 26 days, near the low end of historical ranges, and internal inventory fell by $22 million in the quarter, bringing total inventory reduction to $320.9 million from the December 2024 peak. Normalizing channel inventory is the precondition for higher factory utilization and the margin expansion that follows, and the data suggests that milestone is close.
The forward guidance carried equal weight with investors. Q1 fiscal 2027 revenue is guided to $1.442 to $1.469 billion at the midpoint — up 35.3% year-over-year and 11% sequentially — with non-GAAP EPS of $0.67 to $0.71, a substantial step up from the $0.57 just delivered. Non-GAAP operating margin is expected to reach 33% to 34.5%, reflecting the operating leverage that comes as factories ramp utilization to meet recovering demand.
Data center and AI-related design wins in high-speed connectivity and compute added a growth narrative beyond the cyclical recovery, giving investors confidence that Microchip's rebound has durable secular support beneath it.